Professor Ernest Weil

member of IKA, Amsterdam

juni 2010 – heden (6 jaar 2 maanden)

Urological oncology


 

Urologist

Slotervaartziekenhuis , Amsterdam

februari 2010 – heden (6 jaar 6 maanden)

dr. med. FEBU. Urologist, Chairman Department of Urology

Slotervaart Hospital Amsterdam

februari 2010 – heden (6 jaar 6 maanden)

General Urology, Reconstructive Urology, Neuro Urology, functional Urology, Oncology, Urolithiasis, Paediatric Urology, Incontinence


 

founder and president

Stef foundation , General aid for Childern Foundation

augustus 1997 – heden (19 jaar)

 

Dr Weil started 15 years ago to treat childern with urological congenital malformation in Bali.

His first patient was a just born boy with anal atresia , peno-scrotal hypospadia andnon- descended testis. After Anal and peno-scrotal operations the boy is now 15 years old and a healthy boy. Since then every year dr weil is performing 5 to ten hypospadia repairs in Bali.All costs involved for these operations are taken care of by the foundation.


 

dr , med, FEBU, Urologist, Associate Professor of Urology

Maastricht University Medical Centre

augustus 1983 – juni 2010 (26 jaar 11 maanden)

General Urologist, Neuro Urology, Paediatric urology, Incontinence, Functional Urology, Oncology, Urolithiasis, Reconstructive Urology. Teacher of Urologists in training, Teacher of Students in Medicine.

 


Links:

https://nl.linkedin.com/in/ti2008ew


List of Publications:

  • 1: van Voskuilen AC, Oerlemans DJ, Gielen N, Lansen-Koch SM, Weil EH, van Lankveld JJ, van den Hombergh U, Baeten CG, van Kerrenbroeck PE. Sexual response in patients treated with sacral neuromodulation for lower urinary tract symptoms or fecal incontinence. Urol Int. 2012;88(4):423-30. doi: 10.1159/000336911. Epub 2012 Apr 26. PubMed PMID: 22538447.
  • 2: van Voskuilen AC, Oerlemans DJ, Weil EH, de Bie RA, van Kerrebroeck PE. Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study. Eur Urol. 2006 Feb;49(2):366-72. Epub 2006 Jan 4. PubMed PMID: 16413105.
  • 3: Oerlemans DJ, van Voskuilen AC, Marcelissen T, Weil EH, de Bie RA, Van Kerrebroeck PE. Is on-demand sacral neuromodulation in patients with OAB syndrome a feasible therapy regime? Neurourol Urodyn. 2011 Nov;30(8):1493-6. doi: 10.1002/nau.21070. Epub 2011 Aug 8. PubMed PMID: 21826713.
  • 4: Van Voskuilen AC, Oerlemans DJ, Weil EH, van den Hombergh U, van Kerrebroeck PE. Medium-term experience of sacral neuromodulation by tined lead implantation. BJU Int. 2007 Jan;99(1):107-10. Epub 2006 Sep 6. PubMed PMID: 16956350.
  • 5: Lansen-Koch SM, Govaert B, Oerlemans D, Melenhorst J, Vles H, Cornips E, Weil EH, van Heurn E, Baeten CG, van Gemert WG. Sacral nerve modulation for defaecation and micturition disorders in patients with spina bifida. Colorectal Dis. 2012 Apr;14(4):508-14. doi: 10.1111/j.1463-1318.2011.02678.x. PubMed PMID: 21689346.
  • 6: Janknegt RA, Baeten CG, Weil EH, Spaans F. Electrically stimulated gracilis sphincter for treatment of bladder sphincter incontinence. Lancet. 1992 Nov 7;340(8828):1129-30. PubMed PMID: 1359213.
  • 7: Janknegt RA, Heesakkers JP, Weil EH, Baeten CG. Electrically stimulated gracilis sphincter (dynamic graciloplasty) for treatment of intrinsic sphincter deficiency: a pilot study on feasibility and side effects. J Urol. 1995 Nov;154(5):1830-3. PubMed PMID: 7563357.
  • 8: van Voskuilen AC, Weil EH, De Bie RA, van Kerrebroeck EV. Ten years' experience in neuromodulation in maastricht. Neuromodulation. 2005 Jul;8(3):183-5. doi: 10.1111/j.1525-1403.2005.05237-2.x. PubMed PMID: 22151489.
  • 9: van Voskuilen AC, Weil EH, van Kerrebroeck EV. Tined lead implantation: results of the first 37 implants in maastricht. Neuromodulation. 2005 Jul;8(3):182-3. doi: 10.1111/j.1525-1403.2005.05237-1.x. PubMed PMID: 22151488.
  • 10: Scheepens WA, Van Koeveringe GA, De Bie RA, Weil EH, Van Kerrebroeck PE. Long-term efficacy and safety results of the two-stage implantation technique in sacral neuromodulation. BJU Int. 2002 Dec;90(9):840-5. PubMed PMID: 12460343.
  • 11: Weil EH, Ruiz-Cerdá JL, Eerdmans PH, Janknegt RA, Bemelmans BL, van Kerrebroeck PE. Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized clinical trial. Eur Urol. 2000 Feb;37(2):161-71. PubMed PMID: 10705194.
  • 12: Scheepens WA, de Bie RA, Weil EH, van Kerrebroeck PE. Unilateral versus bilateral sacral neuromodulation in patients with chronic voiding dysfunction. J Urol. 2002 Nov;168(5):2046-50. PubMed PMID: 12394705.
  • 13: Scheepens WA, Jongen MM, Nieman FH, de Bie RA, Weil EH, van Kerrebroeck PE. Predictive factors for sacral neuromodulation in chronic lower urinary tract dysfunction. Urology. 2002 Oct;60(4):598-602. PubMed PMID: 12385915.
  • 14: Dijkema HE, Weil EH, Mijs PT, Janknegt RA. Neuromodulation of sacral nerves for incontinence and voiding dysfunctions. Clinical results and complications. Eur Urol. 1993;24(1):72-6. PubMed PMID: 8396034.
  • 15: Weil EH, Ruiz-Cerdá JL, Eerdmans PH, Janknegt RA, Van Kerrebroeck PE. Clinical results of sacral neuromodulation for chronic voiding dysfunction using unilateral sacral foramen electrodes. World J Urol. 1998;16(5):313-21. PubMed PMID: 9833310.
  • 16: Scheepens WA, van Koeveringe GA, de Bie RA, Weil EH, van Kerrebroeck PE. Urodynamic results of sacral neuromodulation correlate with subjective improvement in patients with an overactive bladder. Eur Urol. 2003 Mar;43(3):282-7. PubMed PMID: 12600432.
  • 17: van Kerrebroeck EV, Scheepens WA, de Bie RA, Weil EH. European experience with bilateral sacral neuromodulation in patients with chronic lower urinary tract dysfunction. Urol Clin North Am. 2005 Feb;32(1):51-7. Review. PubMed PMID: 15698876.
  • 18: Laduc R, Weil EH, Zerbib M, Perrin P, Denis L. Thermotherapy and Hyperthermia Workshop. Prog Clin Biol Res. 1994;386:487-98. PubMed PMID: 7528419.
  • 19: Scheepens WA, Weil EH, van Koeveringe GA, Rohrmann D, Hedlund HE, Schurch B, Ostardo E, Pastorello M, Ratto C, Nordling J, van Kerrebroeck PE. Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation--a multicenter study. Eur Urol. 2001 Oct;40(4):434-8. PubMed PMID: 11713399.
  • 20: Tjandra BS, Daemen MJ, Weil EH. Papillary mesothelioma of the albuginea testis. Urology. 1994 Jan;43(1):118-20. Review. PubMed PMID: 8284873.
  • 21: Fernandez del Moral P, Litjens TT, Weil EH, Debruyne FM. Can combined DES and LHRH depot therapy (ICI 118630) prevent endocrinologic and clinical flare-up in metastatic prostate cancer? Urology. 1988 Aug;32(2):137-40. PubMed PMID: 2969641.
  • 22: Litjens TT, Fernandez del Moral P, van Laarhoven JP, Weil EH, Debruyne FM. [Treatment of advanced prostate carcinoma with a depot form of an LH-RH analog: preliminary endocrinological and clinical results]. Ned Tijdschr Geneeskd. 1986 Apr 26;130(17):787-90. Dutch. PubMed PMID: 3086754.
  • 23: Denis L, Keuppens F, Mahler C, Debruyne FM, Weil EH, Lunglmayr G, Newling D, Robinson MR, Richards B, Smith PH, et al. Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer. Prog Clin Biol Res. 1987;243A:221-7. PubMed PMID: 2958852.
  • 24: Janknegt RA, Weil EH, Eerdmans PH. Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant. Urology. 1997 Mar;49(3):358-62. PubMed PMID: 9123698.
  • 25: Dijkema HE, Weil EH, Janknegt RA. [Initial experiences with neuromodulation as treatment for incontinence and micturition disorders in The Netherlands]. Ned Tijdschr Geneeskd. 1992 Jan 11;136(2):88-90. Dutch. PubMed PMID: 1732834.
  • 26: Weil EH, Eerdmans PH, Dijkman GA, Tamussino K, Feyereisl J, Vierhout ME, Schmidbauer C, Egarter C, Kölle D, Plasman JE, Heidler H, Abbühl BE, Wein W. Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study. Int Urogynecol J Pelvic Floor Dysfunct. 1998;9(3):145-50. PubMed PMID: 9745973.
  • 27: Berghmans LC, Frederiks CM, de Bie RA, Weil EH, Smeets LW, van Waalwijk van Doorn ES, Janknegt RA. Efficacy of biofeedback, when included with pelvic floor muscle exercise treatment, for genuine stress incontinence. Neurourol Urodyn. 1996;15(1):37-52. PubMed PMID: 8696355.
  • 28: Weil EH, van Waalwijk van Doorn ES, Heesakkers JP, Meguid T, Janknegt RA. Transvaginal ultrasonography: a study with healthy volunteers and women with genuine stress incontinence. Eur Urol. 1993;24(2):226-30. PubMed PMID: 8375444.
  • 29: Leunissen KM, Weil EH, Mooy JM, Ausems MM, Kootstra G, van Hooff JP. Bladder stones as an unusual cause of posttransplant macroscopic hematuria. Transplantation. 1987 Oct;44(4):582-3. PubMed PMID: 3313849.
  • 30: Spinelli M, Weil E, Ostardo E, Del Popolo G, Ruiz-Cerdá JL, Kiss G, Heesakkers J. New tined lead electrode in sacral neuromodulation: experience from a multicentre European study. World J Urol. 2005 Jul;23(3):225-9. Epub 2005 Jun 30. PubMed PMID: 15988594.
  • 31: Weil EH, Ruiz-Cerdá JL, van den Bogaard AE, van Kerrebroeck PE. Novel test lead designs for sacral nerve stimulation: improved passive fixation in an animal model. J Urol. 2000 Aug;164(2):551-5. PubMed PMID: 10893642.
  • 32: Meier AH, Weil EH, van Waalwijk van Doorn ES, Verhaegh GT, Janknegt RA. Transurethral radiofrequency heating or thermotherapy for benign prostatic hypertrophy: a prospective trial on 65 consecutive cases. Eur Urol. 1992;22(1):39-43. PubMed PMID: 1385144.
  • 33: Debruyne FM, Denis L, Lunglmayer G, Mahler C, Newling DW, Richards B, Robinson MR, Smith PH, Weil EH, Whelan P. Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma. J Urol. 1988 Oct;140(4):775-7. PubMed PMID: 2971119.
  • 34: Stassen CM, Weil EH, Janevski BK. Left renal vein compression syndrome ("nutcracker phenomenon"). Rofo. 1989 Jun;150(6):708-10. PubMed PMID: 2544950.
  • 35: Vles JS, Grubben CP, van Ooy A, Weil EH. Holocord astrocytomas in childhood. Clin Neurol Neurosurg. 1990;92(4):361-4. PubMed PMID: 1963830.
  • 36: de Jonge MK, van der Beek C, Weil EH, Coolsaet BL. Antegrade ureteroscopy: a new tool in management of severe ureteral strictures. Urology. 1986 Jan;27(1):49-52. PubMed PMID: 3942021.
  • 37: Leonard CD, Weil E, Scribner BH. Subdural haematomas in patients undergoing haemodialysis. Lancet. 1969 Aug 2;2(7614):239-40. PubMed PMID: 4184109.